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Abstract
Background
Hospital inpatients often experience medical and psychiatric problems simultaneously.
Although this implies a certain relationship between healthcare utilization and costs, this
relationship has never been systematically reviewed.
Objective
The objective is to examine the extent to which medical-psychiatric comorbidities relate to
health-economic outcomes in general and in different subgroups. If the relationship is signifi-
cant, this would give additional reasons to facilitate the search for targeted and effective
treatments for this complex population.
Method
A systematic review in Embase, Medline, Psycinfo, Cochrane, Web of Science and Google
Scholar was performed up to August 2016 and included cross-references from included
studies. Only peer-reviewed empirical studies examining the impact of inpatient medical-
psychiatric comorbidities on three health-economic outcomes (length of stay (LOS), medical
costs and rehospitalizations) were included. Study design was not an exclusion criterion,
there were no restrictions on publication dates and patients included had to be over 18
years. The examined populations consisted of inpatients with medical-psychiatric comorbid-
ities and controls. The controls were inpatients without a comorbid medical or psychiatric
disorder. Non-English studies were excluded.
Results
From electronic literature databases, 3165 extracted articles were scrutinized on the basis
of title and abstract. This resulted in a full-text review of 86 articles: 52 unique studies were
included. The review showed that the presence of medical-psychiatric comorbidity was
related to increased LOS, higher medical costs and more rehospitalizations. The meta-
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analysis revealed that patients with comorbid depression had an increased mean LOS of
4.38 days compared to patients without comorbidity (95% CI: 3.07 to 5.68, I2 = 31%).
Conclusions
Medical-psychiatric comorbidity is related to increased LOS, medical costs and rehospitali-
zation; this is also shown for specific subgroups. This study had some limitations; namely,
that the studies were very heterogenetic and, in some cases, of poor quality in terms of risk
of bias. Nevertheless, the findings remain valid and justify the search for targeted and effec-
tive interventions for this complex population.
Introduction
Hospital inpatients often experience medical and psychiatric problems simultaneously. For
patients who are admitted to hospitals for a general medical illness, the prevalence of a comor-
bid psychiatric disorder is estimated at 40% [1]. Conversely, psychiatric patients are at
increased risk of developing comorbid general medical disorders [2]. The consequences of
concurrent general medical and psychiatric illnesses include an increase in morbidity, mortal-
ity, healthcare utilization and costs [3]. All psychiatric disorders are associated with increased
morbidity, and mortality and patients who suffer from eating disorders and substance depen-
dence have the highest risk[4–7]. Numerous studies examined the relationship between medi-
cal-psychiatric comorbidities and health-economic outcomes. Most studies have evaluated the
impact of comorbidities on three outcome measures: length of stay (LOS), medical costs and
rehospitalization rates [8–12]. These parameters are considered major cost drivers in health-
care [13]. Although these studies suggest that medical-psychiatric comorbidities relate to
health-economic outcomes, these outcomes have never been reviewed systematically. Further-
more, the nature of the relationship may be different for separate subgroups [8, 11, 14, 15].
Meta-analyses on this subject have not been performed and, therefore, the overall pooled effect
of the relationship between medical-psychiatric comorbidities and health-economic outcomes
remains unknown.
Aims of the study
The aims of our study were as follows: 1) a systematic review of the literature to examine the
relationship between medical-psychiatric comorbidity and health-economic outcomes; 2) an
examination of possible differences in health-economic outcomes in patient subgroups; 3) an
examination of the pooled-effect sizes for the effects of medical-psychiatric comorbidities on
LOS, medical costs and rehospitalizations using meta-analyses. The importance of this review
lies in its contribution to a cost-effective treatment of this complex and expensive population
[16]. Policy makers might use the estimation of pooled-effect sizes for the effects of medical-
psychiatric comorbidity on the examined health-economic outcomes to improve the delivery
of cost-effective care for patients with medical-psychiatric comorbidities. Furthermore, this
review might stimulate future researchers to examine the impact of several subgroups with
comorbidity on different health-economic outcomes more thoroughly.
Method
The literature was scrutinized by making queries in electronic literature databases and by
examining cross-references in the included articles. Six electronic literature databases were
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examined: Embase, Medline, Cochrane, Psycinfo, Web of Science and Google Scholar. The
data extraction was performed on March 3, 2015 by a biomedical information specialist and
updated on August 1, 2016: the search terms used are shown in Table 1 and an example of a
full electronic search is provided in Table 2. The search terms were adjusted to comply with
the specifications of the different databases. Duplicates and non-English articles were removed.
A literature search based on cross-referencing was performed on November, 27, 2015. As no
new articles were included after updating the search on August 1, 2016, no new cross-referenc-
ing was performed after this point.
Inclusion criteria
Empirical studies that examine the effect of having either medical or psychiatric comorbidity
in hospital inpatients are included. These hospital inpatients have to be either primarily medi-
cally or psychiatrically ill and aged 18 years or older. Studies had to measure the effect on any
of three major health economic outcomes (length of stay and/or medical costs and/or rehospi-
talization), and must be published in a peer-reviewed journal. Any measure of LOS (days,
mean, median, et cetera), all types of medical costs (direct and indirect), and all reports of
rehospitalization (all relevant time-frames) were included as the aim was to broadly review the
literature on these outcomes. Inclusion criteria were limited to these outcomes since these are
most reported in literature. It was hypothesized that medical-psychiatric comorbidity has a sig-
nificant impact on these outcomes; it was further expected that effects were most prominent
for inpatients, because these patients are presumed to be the most severely ill. By focusing on
these inclusion criteria, we aimed to decrease heterogeneity between included studies. Conse-
quently, study design was not an exclusion criterion, there were no restrictions on publication
dates. Additionally, the examined populations had to consist of inpatients with medical-psy-
chiatric comorbidities and controls. The controls were required to be patients without a
comorbid medical or psychiatric disorder; however, the way the controls were sampled was
not an exclusion criterion. Non-English articles were excluded.
Ideally, a comparison of comorbid patients (disease A and B) with patients that only have
disease A or only disease B would be made. In this way, discerning whether the effect was addi-
tive or multiplicative could be estimated. However, only inpatients with disease A or B were
included and compared with disease AB for reasons of feasibility.
Table 1. Search terms systematic review.
psychosomatics OR somatic OR physical OR medical OR medicine NEAR psychiatr OR mental OR cognit
OR psychosomatic AND comorbidity OR comorbid multi OR poly OR co NEAR morbid OR pathologOR co
OR coexist OR disorder AND ’hospital patient OR hospitalization OR outpatient OR ’outpatient care’ OR
’ambulatory care OR ’outpatient department OR hospital OR general hospital OR hospital admission OR ’hospital
care OR ’university hospital OR ’hospital discharge OR hospital department OR ward OR hospital OR inpatient
OR outpatient OR ward OR ambulatory).
https://doi.org/10.1371/journal.pone.0194029.t001
Table 2. Full electronic search strategy in Embase.
(psychosomatics/exp OR (((somatic OR physical OR medical OR medicine) NEAR/6 (psychiatr OR mental OR
cognit)) OR psychosomatic):ab,ti) AND (comorbidity/exp OR ’cluster analysis’/exp OR (comorbid OR cluster
OR ((multi OR poly OR co) NEAR/3 (morbid OR patholog)) OR (co NEXT/1 exist) OR coexist OR (mixed
NEAR/3 disorder)):ab,ti) AND (’hospital patient’/exp OR hospitalization/exp OR outpatient/exp OR ’outpatient
care’/exp OR ’ambulatory care’/exp OR ’outpatient department’/exp OR hospital/de OR ’general hospital’/de OR
’hospital admission’/exp OR ’hospital care’/exp OR ’university hospital’/exp OR ’hospital discharge’/exp OR
’hospital department’/de OR ward/de OR (hospital OR inpatient OR outpatient OR ward OR ambulator):ab,ti)
NOT ([Conference Abstract]/lim OR [Letter]/lim OR [Note]/lim OR [Conference Paper]/lim OR [Editorial]/lim)
AND [english]/lim
https://doi.org/10.1371/journal.pone.0194029.t002
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Selection procedure
Two authors (LAWJ and MAvS) independently assessed 100 randomly selected titles and
abstracts to validate the inclusion criteria. All obtained articles were then reviewed on the basis
of title and abstract by the first author. Full texts of the included articles were then obtained.
Subsequently, two authors (LAWJ and JAvW) independently assessed the selected articles in a
standardized manner to further include or exclude articles for the review. Consensus was
sought when disagreements between the authors on inclusion existed. When no consensus
could be reached, the assessment of a third author (MAvS) was decisive. An intra-class correla-
tion coefficient was calculated to examine the accuracy of match between the reviewers.
Thereafter, two authors (LAWJ and JAvW) read all included articles and extracted relevant
data about nine predetermined characteristics: study design, patient characteristics, somatic
diagnoses, psychiatric diagnoses, control group, moment of data collection (during or after
treatment), LOS, medical costs, and rehospitalization rates. An electronic spreadsheet (Micro-
soft Excel) was used with these predetermined characteristics and available information for
every included article was recorded. Again, disagreements on the collected data were resolved
by discussion and, if no consensus was reached, the assessment of a third author (MAvS) was
decisive.
The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in
meta-analyses was used to assess the risk of bias in each study [17]. The NOS scale has been
developed to assess the quality of non-randomized studies with its design. It uses a “star sys-
tem” that judges a study on three broad perspectives: selection of groups, comparability of
groups, discernment of either the exposure or outcome of interest for case-control or cohort.
All included studies were rated by the first author (LAWJ) based on the NOS; using NOS,
each article was rated on nine variables and could earn a maximum of “9 stars”. More stars
indicates less risk of bias in the assessed article. Finally, in reporting this review, the “Preferred
reporting Items for Systematic reviews and Meta-Analyses” (PRISMA) checklist [18] was used.
A review protocol was not used a priori to this systematic review.
Subgroups were selected based on the number of studies that researched the specific sub-
group. Only the most extensive researched subgroups per health-economic outcome are pre-
sented in this study.
Meta-analyses
Meta- analyses were performed using Review Manager 5.3. In studies that reported continuous
data, only those that stated means and standard deviations were included in the analyses. Fur-
thermore, pooled-effect sizes were only reported if the (sub-)population was reasonable homog-
enous as this is not appropriate for heterogeneous studies [19]. The heterogeneity was based on
statistics where a cut-off point of an I2 of 50% was used. A random-effects model was applied to
calculate treatment effects. In order to express treatment effects, the (standard) mean differences
and 95% confidence intervals (CI) were calculated. The X2 test was used to determine the het-
erogeneity between included studies where I2 values of<25% represent low heterogeneity,
between 25% and 50% represent moderate heterogeneity and values >50% suggest severe het-
erogeneity between the studies [20]. Statistical significance was assumed at P<0.05.
Results
Study selection
The systematic literature search resulted in a total of 6163 articles. After removing duplicates
and non-English articles, a total of 3165 studies remained. After reviewing all studies on title
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and abstract, a total of 86 articles were included for the full-text review. The reviewing authors
agreed on the inclusion of 36 articles and the exclusion of 37 articles; an intra-correlation coef-
ficient of 0.76 between the reviewers was estimated. Consensus was not reached for thirteen
articles; after discussion, eight of these were included and five excluded. References in all 44
included articles were cross-checked. This resulted in ten extra articles to review in full text,
eight of which were included. These studies did not appear in the search since the title did not
refer to medical-psychiatric comorbidity but to a specific disorder. Finally, after the selection
procedure, a total of 52 articles entered the definite literature review (“Fig 1”).
A variety of study designs were included, mostly observational in nature. Longitudinal
cohort study was the most common design. No randomized clinical trials were found.
All studies compared either a medical or psychiatric index disorder, 48 articles examined
patients with a medical index disorder and a psychiatric comorbid disorder and, conversely,
four articles examined atiens with a psychiatric index disorder and a medical comorbid disor-
der. The control groups consisted of inpatients without a medical or psychiatric comorbid dis-
order. The number of participants in the reviewed studies ranged from 63 to 1,617,710
patients. The impact of medical-psychiatric comorbidities on LOS was described in 42 (81%)
articles, the impact on costs in 12 (23%) articles and on rehospitalization in ten (19%) articles.
The risk of bias was assessed using the NOS and the scores ranged from the minimum (one
star) to the maximum number (nine) of stars. Details of the individual studies are presented in
Table 3, which is divided by outcome measure and sorted according to the NOS grading sys-
tem. No additional risk of bias was performed: the risk of publication bias was low since both
negative and positive findings were of interest for all measures (LOS, costs, rehospitalization).
Results of individual studies
Impact of medical-psychiatric comorbidities on LOS. Table 3 shows the results of the 42
included studies that examined the impact of medical-psychiatric comorbidities on LOS. Arti-
cles with the least risk of bias are shown at the top of the table and are arranged according to
Fig 1. Flowchart of study results.
https://doi.org/10.1371/journal.pone.0194029.g001
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Table 3. Impact of medical-psychiatric comorbidity on length of stay (LOS), medical cost and rehospitalization.
Impact of medical psychiatric comorbidity on Length Of Stay
Study N Index disorder Comorbid disorder Control group Length-of-stay (LOS) in days NOS
Mai et al. [21],
2011
433.388 Diabetes, COPD, congestive heart
failure, convulsions and epilepsy.
Alcohol/drug disorders,
Schizophrenia Affective psychoses,
Other psychoses Neurotic
disorders, Personality disorders
Adjustment disorders, Depressive
disorders, Other mental disorders
No psychiatric
comorbidity
Average LOS with comorbidity 6.1
vs. without comorbidity 4.4.
9
Furlanetto
et al.[22], 2003
317 Cardiovascular, Gastrointestinal,
Neoplasms, Pulmonary, Infectious
Cognitive impairment, depressive
disorders, substance related
disorders, adjustment disorders,
anxiety disorders
No psychiatric
comorbidity
Mean LOS with comorbidity 14.7
(SD 13.8) vs. without comorbidity
12.1(SD 9.9), LOS with comorbid
cognitive impairment significantly
prolonged (F = 17.8 P<0.01).
8
Bressi et al.
[23], 2006
1.617.710 In order to identify patients
hospitalized for medical
conditions, patients having a
primary mental diagnosis were
excluded
Schizophrenia, major mood
disorders and substance abuse
disorders
No psychiatric
comorbidity
Mean LOS with comorbidity 0.15
days longer (P<0.001) vs. patients
without comorbidity.
Mean LOS with comorbid
schizophrenia 0.86 days longer
(P<0.0001)
Mean LOS with comorbid mood
disorder 0.26 days longer
(P<0.0001)
Mean LOS with substance abuse
0.25 shorter (P<0.001)
8
Hansen et al.
[24], 2001
157 Consecutive inpatients department
of internal medicine
Patients with comorbid mental
illness
No psychiatric
comorbidity
OR LOS> = 10 days with any
mental disorder = 0.5 (0.2–1.3)
OR LOS> = 5 days with any mental
disorder = 0.9 (0.4–2.4)
8
Saravay et al.
[25], 1991
278 Patients from medical, surgical
and gynecology floor
Psychiatric illness; measured with
MMSE, Zung Depression
Inventory, SCL-90
No psychiatric
comorbidity
Mean LOS is significantly related
with comorbid organicity
(p = 0.004), depression (p = 0.03),
and anxiety (p = 0.05)
8
Bourgeois
et al. [26],
2005
31.846 All medical diagnosis All psychiatric illness No psychiatric
comorbidity
Mean LOS with comorbid
adjustment disorder 5.68 (1999),
7.96 (2000) 8.85 (2001) vs. no
psychiatric disorder and substance
use disorders 3.29, 3.43, 3.51
respectively (P<0.001).
8
Benzer et al.
[27], 2012
21.716 All medical diagnosis Patients with post discharge
mental health care
No psychiatric
comorbidity
Mean LOS with post-discharge
mental health care: 7.86 (SD21.1) vs
no mental health care post-
discharge: 7.2 (SD15.4) days (non
sig.)
8
Fulop et al.
[28], 1989
66.637 Craniotomy, nervous system
neoplasm, cerebrovascular
disorder, respiratory neoplasm,
bronchitis and asthma, circulatory
disorder, heart failure l, bowel
procedure, digestive malignancy,
cirrhosis, renal failure,
chemotherapy, operation room
procedure
All psychiatric diagnosis No psychiatric
comorbidity
All 13 somatic diagnosis related
groups (DRG) with psychiatric
comorbidity have significant longer
mean LOS than without
comorbidity.
8
Levenson et al.
[29], 1990
455 All medical diagnosis Very depressed; very anxious;
cognitive impairment; high pain
levels;
Low level of
psychopathology
Mean LOS in high level patients:
11.5 (SD12.4) in low level 8.7
(SD11.9) (P<0.001)
8
Fulop et al.
[30], 1987
59.259 All medical and surgical patients Organic mental disorder
(delirium, substance abuse)
No psychiatric
comorbidity
Mean LOS with comorbidity: 19.8
(SD33.3) vs. without 9.2 (SD15.3)
(p– 0.001) in NYC; 13.7 (SD27.7) vs.
8.3 (SD13.2) in Chicago (p– 0.001)
7
(Continued)
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Table 3. (Continued)
Hochlehnert
et al. [11],
2011
1063 Cardiovascular inpatients Depressive disorders, anxiety
disorders, somatoform disorders,
organic psychiatric disorders,
adjustment disorders, substance
dependence, schizophrenic
disorders, and other diagnosis
No psychiatric
comorbidity
Mean LOS of patients with
psychiatric comorbidity
significantly longer compared to
patients without psychiatric
comorbidity (F1.11 = 34.04;
p<0.001)
7
Schubert et al.
[31], 1995
532 Psychosis, depression, personality
disorder, anxiety disorder,
adjustment disorder, bipolar
disorder, other psychiatric
disorders
Physical illness No somatic
comorbidity
Mean LOS significant longer with
comorbidity 19.31 vs. without 13.13.
Depression with somatic
comorbidity significant longer 20.08
(SD 24.8) than without 11.48 (SD
11.88)
7
Zatzick et al.
[32], 2000
10.561 Diabetes, hypertension, chronic
liver disease, ischemic heart
disease, degenerative nervous
conditions, epilepsy, obesity, and
coagulation defects, HIV infection
Alcohol abuse, alcohol
dependence, drug abuse, drug
dependence, anxiety disorders,
bipolar disorders, childhood
disorders, delirium, dementia,
depression, disorders attributable
to organic brain damage,
personality disorders, psychoses,
stress disorders, and other
disorders
No psychiatric
comorbidity
Mean LOS 10% shorter with alcohol
abuse (p = <0.01) than without.
Mean LOS 60% to 103% longer with
delirium, psychoses and stress-
disorder (p = <0.01) than without.
7
Koenig et al.
[33], 1998
542 60 years and older cardiology and
neurology patients
Depressed patients; No psychiatric
comorbidity
Mean LOS with comorbid major
depression 12.1 (SD19.8) vs.
without depression 5.7 (SD12.8) (p
= <0.001)
7
Fulop et al.
[34], 1998
467 Patients 65 years or older with a
medical disorder
Cognitive impairment, depression
or anxiety disorder
No psychiatric
comorbidity
Mean LOS with comorbidity 13.1
(SD13.0) vs. without 10.5 (SD11.7)
(P = 0.025). LOS with depressive
disorder 11.0 (SD13.1) vs. without
11.8 (SD12.5) (P = 0.51)
7
Adams et al.
[8], 2015
12.283 Patients 65 years or older with a
medical disorder
Organic, substance abuse,
schizophrenia, mood, neurotic/
stress, physiological/physical,
personality disorder
No psychiatric
comorbidity
Mean LOS with comorbidity 16.06
vs. without 11.5 (p = <0.001)
7
Ismail et al.
[12], 2014
477 All medical diagnosis Dementia; subgroup psychosis
(with or without dementia)
No psychiatric
comorbidity
Mean LOS geriatric dementia
patients 74.7 (SD93.7) without
dementia 69.9 (SD87.5). Geometric
mean LOS 38.1 with dementia vs.
34.6 without (p = 0.32)
7
Hosaka et al.
[35], 1999
65 Malignancy Major depression No psychiatric
comorbidity
Mean LOS benign with major
depression 135.0 (SD160.7) without
69.7(SD61.9) (P = <0.05).
7
Sayers et al.
[36], 2007
20.429 Patients 65 years of older with one
acute care hospitalization of
congestive heart failure.
Alcohol abuse, drug abuse,
psychosis, depression, bipolar
disorders, anxiety disorders, and
other psychiatric conditions
No psychiatric
comorbidity
Comorbid psychoses additional
mean LOS 1.06 days (P = <0.001)
Comorbid depression additional
mean LOS 0.89 days (P = <0.001)
Comorbid bipolar disorder
additional mean LOS 1.43 days
(P = 0.02)
7
Smith et al.
[37], 2014
63 Idiopathic Pulmonary Fibrosis
(IPF), COPD, CF
Delirium No psychiatric
comorbidity
Presence of delirium was associated
with longer duration of
hospitalization (p = 0.006)
6
Wancata et al.
[38] 2001
821 Diseases of the circulatory system,
diseases of digestive and
genitourinary system
Dementia, minor depression and
substance abuse disorders
No psychiatric
comorbidity
Mean LOS with comorbidity 17.6
vs. without 11.5. Dementia 1.35
(1.16–1.57) substance abuse
disorders 1.24(1.04–1.48) Alcohol-
& drug related psychiatric disorders
1.54(1.13–2.11) significantly
associated with longer LOS
6
(Continued)
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Table 3. (Continued)
Ceilley et al
[39]., 2005
87 Depressive disorder, bipolar
disorders, psychotic disorders
Osteoarthritis, viral hepatitis C
COPD
No somatic
comorbidity
Mean LOS with somatic
comorbidity 12.3 (SD5.2) vs. 9.1
(SD 3.7) (P = 0.003)
6
Davydow et al.
[40], 2011
3.591 Diabetes Depression No psychiatric
comorbidity
Mean LOS no depression 7.9
(SD9.9) major depression 12.2
(SD16.8) (P<0.001)
6
Chwastiak
et al. [9], 2014
82.060 Diabetes, Heart failure, renal
failure, hypertension complicated,
peripheral vascular
Bipolar disorder, schizophrenia,
psychotic disorders delusional
disorder and nonorganic
psychoses.
No psychiatric
comorbidity
No comorbidity median 3 days
Inter Quartile Rang (IQR): 2–4 vs.
severe Mental illness: median 3 days
IQR: 2–4
6
Bourgeois
et al. [41],
2006
155 All medical diagnosis Delirium, dementia, and both General hosp.
population
Mean LOS with comorbidity 13 vs.
3 without.
6
Bourgeois
et al. [15],
2009
157 Hospital population Cognitive disorders (primarily
dementia and delirium or both)
No psychiatric
comorbidity
Mean LOS with comorbidity 18.6
vs. 3 without.
6
Stevens et al.
[42], 1998
42 All medical diagnosis Delirious patients No psychiatric
comorbidity
Median LOS cases 20.0 (1–117) vs.
controls 8.0 (1–171), delirious LOS
sig. longer 2.2 (1.5–3.3) than
controls
6
Uldall et al.
[43], 1994
357 Aids Mood disorders, substance use
disorders, organic psychiatric
disorders, anxiety disorders, and
adjustment disorders
No psychiatric
comorbidity
LOS with comorbidity 16.8
(SD15.0) vs. without 10.2 (SD19.1)
(P = 0.01)
6
Borckardt
et al. [44] 2011
10.865 All medical diagnosis except
emergency room stays
Patients receiving outpatient
treatment
No psychiatric
comorbidity
Mean LOS with inpatient psychiatry
consultation 9.39 vs. without 4.63 (P
= <0.001)
6
Boustani et al.
[45], 2010
995 Patients 65 or older admitted to
medical services
Delirium No psychiatric
comorbidity
Mean LOS with comorbid delirium
9.2 vs. 5.9 without (P = <0.001)
5
Morris et al.
[46], 1990
110 Peptic ulcer parenchymal liver
disease intestinal malignancy
General Health Questionnaire
(GHQ) case
GHQ noncase Mean LOS with comorbidity 8.7
(SD5.9) vs. without 8.3 (SD5.7)
(non-significant)
5
Verbosky et al.
[47], 1993
48 All Depression No psychiatric
comorbidity
Mean LOS with comorbid
depression 20 (range 2–95) vs.
without 10 (range 2–51) (P = 0.02)
5
Erdur et al.
[48], 2012
41 Anorexia Nervosa (AN) Predominantly internal diseases No somatic
comorbidity
Mean LOS with somatic
comorbidity 66.6 (SD50.3) vs.
without 50.0 (SD47.0) (P = 0.05)
4
Sloan et al.
[49], 1999
2323 Psychosis, depression, personality
disorder, anxiety disorder,
adjustment disorder, bipolar
disorder, other disorders
Physical illnesses were limited to
those appearing in the (ICD 9)
No somatic
comorbidity
Mean LOS with somatic
comorbidity 20.0 vs. without 16.6 (P
= <0.001)
4
Ackerman
et al. [50],
1988
92 All medical diagnosis A form of depressive disorder No psychiatric
comorbidity
Mean LOS with comorbid
depression 2.52 days longer than
without (P<0.001)
4
Uldall et al.
[51], 1998
2834 AIDS Dementia, delirium,
schizophrenia, psychosis,
depression, bipolar-, anxiety-,
adjustment-, personality-disorder,
alcohol-, drug-dependence,
alcohol-, drug-abuse
No psychiatric
comorbidity
Median LOS with comorbidity 9.0
vs. without 7.0 (P = <0.001)
4
McCusker
et al. [52],
2003
359 Patients 65 or older with a medical
admission
Delirium No psychiatric
comorbidity
Mean LOS prevalent delirium 16.2
(SD13.2) vs. without 12.6(SD11.8)
(non sig.)
Mean LOS incident delirium 20.2
(SD14.2) vs. without 10.7(SD9.8)
(sig.)
4
(Continued)
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Table 3. (Continued)
Creed et al.
[53], 2002
263 Patients admitted to an acute
medical ward
Depression and anxiety No psychiatric
comorbidity
Median LOS with comorbidity 9.0
(6–20) vs. 7.0 (4–18) without (non
sig.)
4
Schubert et al.
[54], 1992
31 Stroke or Amputation Depression, according to the
geriatric depression scale
No psychiatric
comorbidity
Correlation CVA and depression
+0.575 (P<0.05) an between
amputation patients and depression
+0.266 (non. sig) indicating longer
LOS
4
Douzenis et al.
[55] 2012
428 Schizophrenia and bipolar patients Endocrine Circulatory Nervous
Respiratory Musculoskeletal Blood
Skin
No somatic
comorbidity
Mean LOS with comorbid bipolar
disorder 16.8 (SD8.8) was
significantly lower than comorbid
schizophrenia 19.57 (SD11.2).
4
Mojet et al.
[57], 1989
17687 All medical diagnosis Consultation Liaison (C-L) No CL
consultation
Mean LOS with CL 26.1 vs. without
11.1
4
Johansen et al.
[56] 2012
Not
reported
Patients admitted to an acute care
medical ward
Patients with mental illness (most:
organic (delirium/dementia),
mood disorders and
schizophrenia)
No psychiatric
comorbidity
Average LOS with comorbidity 15.3
vs. without 5.8. Comorbidity
2.7-fold increase in LOS vs. without
comorbidity.
1
Impact of medical psychiatric comorbidity on medical costs
Study N Index disorder Comorbid disorder Control group Length-of-stay (LOS) in days NOS
Benzer et al.
[27], 2012
21.716 All medical diagnosis Patients with post discharge
mental health care
No psychiatric
comorbidity
Total cost (inpatient, outpatient and
pharmacy costs) ($) with mental
health care post-discharge: 29.566
(SD 31.577) vs. without 20.611 (SD
26.855) (non sig.)
8
Levenson et al.
[29], 1990
455 All medical diagnosis Very depressed; very anxious;
cognitive impairment; high pain
levels;
Low level of
psychopathology
Mean total hospital costs high level
patients 7634 (SD10484) dollar vs.
low level 5643 (SD7411) dollar (P =
<0.003)
8
Hochlehnert
et al. [11], 2011
1063 Cardiovascular inpatients Depressive disorders, anxiety
disorders, somatoform disorders,
organic psychiatric disorders,
adjustment disorders, substance
dependence, schizophrenic
disorders, and other diagnosis
No psychiatric
comorbidity
Average total cost with psychiatric
comorbidity 7663 (SE571) vs.
without 5142 (SE210) (sig.)
7
Druss et al.
[58], 1999
77.183 All medical diagnosis Major depression, depressive
symptoms only, substance abuse,
comorbid depression and
substance abuse
No psychiatric
comorbidity
Total increased inpatient costs
compared to patients without these
comorbidities: depression/substance
abuse 1033$, depressive symptoms
861$, major depression 1581$,
substance abuse 1244$, depression
with substance abuse 4681$
(P<0.001)
7
Haas et al.
[10], 2012
127 Anorexia Nervosa All medical diagnosis No anorexia
nervosa
Number of comorbidity groups per
patient is not significantly related to
increased costs gamma -0.018(0.02)
7
Zatzick et al.
[32], 2000
10.561 Diabetes, hypertension, chronic
liver disease, ischemic heart
disease, degenerative nervous
conditions, epilepsy, obesity, and
coagulation defects, HIV infection
Alcohol abuse, alcohol
dependence, drug abuse, drug
dependence, anxiety disorders,
bipolar disorders, childhood
disorders, delirium, dementia,
depression, disorders attributable
to organic brain damage,
personality disorders, psychoses,
stress disorders, and other
disorders
No psychiatric
comorbidity
Costs 10% decrease with alcohol
abuse (p = <0.01) than without.
Costs 60% to 103% increase with
delirium, psychoses and stress-
disorder (p = <0.01) vs. without.
Total costs in patients with
delirium, psychoses, and stress-
disorders 46% to 93% higher costs
vs. no comorbidity.
7
(Continued)
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Table 3. (Continued)
Adams et al.
[8], 2015
12.283 Patients 65 years or older with a
medical disorder
Organic, substance abuse,
schizophrenia, mood, neurotic/
stress, physiological/physical,
personality disorder
No psychiatric
comorbidity
Hospital costs with mental illness
$24.076 (SD49.320) vs without
mental illness $10.473 (SD17.391)
(P = < 0.001)
7
Sayers et al.
[36], 2007
20.429 Patients 65 years of older with one
acute care hospitalization of
congestive heart failure.
Alcohol abuse, drug abuse,
psychosis, depression, bipolar
disorders, anxiety disorders, and
other psychiatric conditions
No psychiatric
comorbidity
Psychiatric comorbidities,
associated with higher total
hospitalization costs 7.294$
(P = 0.001).
7
Shen et al.
[59], 2008
2440 Asthma, diabetes, heart disease
hypertension and osteoarthritis
Affective disorders, anxiety,
somatoform, dissociative,
personality disorders;
schizophrenia
No psychiatric
comorbidity
Mean inpatient costs with mental
illness 2.731$ vs. without mental
illness 2072$ (non sig.)
6
Borckardt
et al. [44],
2011
10.865 All medical diagnosis except
emergency room stays
Patients receiving outpatient
treatment
No psychiatric
comorbidity
Mean total costs patients receiving
psychiatry consultation 25.773$ vs.
without consultation 9672$ (p <
.001)
6
Welch et al.
[60], 2009
618.780 Asthma, back pain, diabetes,
epilepsy, headache, hypertension,
IVDD, obesity, joint pain, CHF,
CAD
Depressed No psychiatric
comorbidity
Inpatient costs significantly
increased in coronary artery disease
1890$, epilepsy 2.560$ and
congestive heart failure 13900$ vs.
no comorbid depression
5
Creed et al.
[53], 2002
263 Patients admitted to an acute
medical ward
Depression and anxiety No psychiatric
comorbidity
Mean total healthcare costs cases
$8,541 (SE $605) vs. without $5,857
(SE $859) (P = 0.01)
4
Impact of medical psychiatric comorbidity on rehospitalization
Study N Index disorder Comorbid disorder Control group Length-of-stay (LOS) in days NOS
Kartha et al.
[61], 2007
144 Medical inpatients Major depression non-
rehospitalisation
Comorbid depression tripled the
odds of rehospitalization (OR = 3.3)
(95%CI = 1.2 to 9.3)
8
Saravay et al.
[62], 1996
273 Medical and surgical inpatients Depression, obsessive compulsive-,
anxiety disorder, psychoticism,
hostility, interpersonal sensitivity.
No psychiatric
comorbidity
Compared to the rest of the study
group, the cognitively impaired
patients averaged twice as many
rehospitalizations (sig.)
8
Adams et al.
[8], 2015
12.283 Patients 65 years or older with a
medical disorder
Organic, substance abuse,
schizophrenia, mood, neurotic/
stress, physiological/physical,
personality disorder
No psychiatric
comorbidity
Rate of readmission in elderly with
mental illness 1.87 (SD = 1.20) vs
without 1.50 (SD = 1.03)
(P < 0.001)
7
Chang et al.
[63], 2001
164 Digestive and cardiovascular
disease
Major depression and anxiety
disorders
No readmission No significant difference in
readmission between patients with
medical-psychiatric comorbidity
and without
6
Chwastiak
et al. [9], 2014
82.060 Diabetes, Heart failure, renal
failure, hypertension complicated,
peripheral vascular
Bipolar disorder, schizophrenia,
psychotic disorders delusional
disorder and nonorganic
psychoses.
No psychiatric
comorbidity
Increased odds of rehospitalization
in patients with Serous Mental
Illness vs. no SMI within next
month (OR 1.24) (1.07–1.44)
(p = 0.006)
6
Jiang et al.
[64], 2001
374 Congestive heart failure Mild or major depression No psychiatric
comorbidity
Major depression associated with
increased odds of readmission at
3months (OR, 1.9 P = 0.04) and one
year (OR = 3.07 P = 0.005)
6
Borckardt
et al. [44],
2011
10.865 All medical diagnosis except
emergency room stays
Patients receiving outpatient
treatment
No psychiatric
comorbidity
Number of hospitalizations within 6
months with psychiatric
comorbidity 1.6 vs. without 1.34 (p
= .001)
6
Boustani et al.
[45], 2010
995 Patients 65 or older admitted to
medical services
Delirium No psychiatric
comorbidity
Readmission within 30 days after
discharge with delirium 22.5% vs.
without 17.8% (P = 0.50)
5
(Continued)
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the NOS grading system [8, 9, 11, 12, 15, 17, 21–57]. LOS was increased in patients with medi-
cal-psychiatric comorbidities compared to patients without comorbidity in 40 out of 42 (95%)
articles; in 33 (79%) studies, this relationship was statistically significant [8, 11, 15, 23, 25, 26,
28–37, 39–45, 47–52, 55–57]. In five (12%) articles, this relationship was non-significant [9, 12,
27, 46, 53] and in four (10%) articles, no information about statistical significance was given
[21, 22, 24, 38]. The remaining two (5%) studies did not show a relationship [9, 24].
Nineteen (43%) of 42 studies provided data for meta-analysis “Fig 2”. The included studies
appeared very heterogeneous: the range of the mean LOS in the comorbid group varied from
7.7–135.0 versus 7.2–69.8 in the control group. Because of this heterogeneity, the estimation of
an overall pooled effect was not appropriate. Nevertheless, given that all results point in one
direction, “Fig 2” shows that medical-psychiatric comorbidities are related to increased LOS.
Impact of medical-psychiatric comorbidities on medical costs. Table 3 shows the arti-
cles that described the impact of medical-psychiatric comorbidities on medical costs. Out of 12
studies, nine (75%) showed a significant relationship [8, 11, 29, 32, 36, 53, 58–60] and three
(25%) showed a non-significant relationship [10, 27, 59].
Table 3. (Continued)
Uldall et al.
[51], 1998
2834 AIDS Dementia, delirium,
schizophrenia, psychosis,
depression, bipolar-, anxiety-,
adjustment-, personality-disorder,
alcohol-, drug-dependence,
alcohol-, drug-abuse
No psychiatric
comorbidity
Median number of admissions with
comorbidity 2 vs. without 1
(P<0.001)
4
Evans et al.
[65], 1988
532 Medical/surgical patients Psychiatric comorbidity was
defined as any of the ICD-9-CM/
DSM-3 psychiatric diagnosis codes
No psychiatric
comorbidity
No significant difference in
readmission rate between patients
with mental disorders and without.
4
() Only the number of inhospital records is reported, not the number of patients.
https://doi.org/10.1371/journal.pone.0194029.t003
Fig 2. Relation of medical-psychiatric comorbidity and length of stay (LOS) (because the study of Fulop et al. [1987] included two separate samples in
two hospitals, both outcomes are included in the analyses).
https://doi.org/10.1371/journal.pone.0194029.g002
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The results of five (42%) studies were included in a meta-analysis “Fig 3”. These studies
were very heterogenous and, therefore, an estimate of an overall pooled effect was not applica-
ble. However, “Fig 3” reveals that medical-psychiatric comorbidities are related to increased
medical costs.
Impact of medical-psychiatric comorbidities on rehospitalization. Table 3 shows the
impact of medical-psychiatric comorbidities on rehospitalization. This relationship was
described in ten (19%) studies [8, 9, 44, 45, 51, 61–65]; of these, nine (90%) revealed that medi-
cal-psychiatric comorbidities related to increased rehospitalizations. Seven (70%) studies
found a significant increase [[8, 9, 44, 51, 61, 62, 64], two (20%) noted a non-significant
increase [45, 65] and one (10%) found neither an increase nor decrease [63]. A meta-analysis
was not executed since the data could not be used in a meta-analysis.
Impact of different subgroups on health-economic outcomes. In the reviewed studies,
two subgroups–depression and delirium–appeared to be extensively studied and were suitable
for further subgroup analysis.
Impact of comorbid depression and delirium on LOS. The relationship between comor-
bid depression and LOS was examined in 16 out of 43 (37%) studies; of these, 11 studies (69%)
showed a significant relationship [23, 25, 31, 33, 35, 36, 40, 47, 49, 50, 54]; two studies (13%)
showed a non-significant relationship [38, 51], two (13%) no effect [22, 26] and one (6%)
study demonstrated a non-significant relationship between shorter LOS and comorbid depres-
sion [34].
Six studies provided suitable data for meta-analysis; the overall pooled mean difference in
“Fig 4” showed that patients with comorbid depression had an LOS that was 4.38 days longer
than patients without comorbid depression (mean LOS: 4.38 days; 95% CI: 3.07 to 5.68 days).
The weighted average mean LOS of the depressed group was 13.8 days as opposed to 10.5 days
for the non-depressed group.
Fig 3. Relationship between medical-psychiatric comorbidity and medical costs.
https://doi.org/10.1371/journal.pone.0194029.g003
Fig 4. Meta-analysis in the subgroup depression examining the impact on length of stay (LOS).
https://doi.org/10.1371/journal.pone.0194029.g004
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Another extensively studied subgroup consisted of patients with comorbid delirium. Seven
(16%) articles found a relationship between comorbid delirious patients and increased LOS
compared to patients without comorbid delirium; five studies (71%) showed a significant rela-
tionship [32, 37, 42, 45, 52] and two studies (29%) a non-significant relationship [41, 51]. The
data in these articles were not sufficient to perform a meta-analysis.
Impact of comorbid depression on medical costs. The relationship between comorbid
depression and medical costs was examined in six (46%) studies; of these, five (92%) showed
significantly higher medical costs in comorbid depressed patients compared to patients with-
out comorbid depression [29, 36, 53, 58, 60]. One (8%) study indicated a non-significant rela-
tionship [32]. A meta-analysis was not performed as only two articles provided limited data.
Impact of comorbid depression on rehospitalization. The relationship between medi-
cal-psychiatric comorbidities and rehospitalization was, again, extensively examined in the
subgroup with comorbid depression compared to patients without comorbid depression. This
was described explicitly in four (40%) reviewed articles. Two (50%) studies found that the
odds ratio for rehospitalization was significantly higher in patients with comorbid depression
[51, 64]. Another study (25%) showed that patients with comorbid depression and a history of
prior hospitalizations within six months were three times more likely to be rehospitalized
within 90 days [61]. One (25%) study did not find a significant increase of the odds ratio for
rehospitalization in patients with comorbid depression [63]. Meta-analysis for this subgroup
was not possible because only one article provided useful data.
Discussion
To our knowledge this is the first review that examined the relationship between medical-psy-
chiatric comorbidity and health-economic outcomes. Our analysis shows that hospital inpa-
tients having medical-psychiatric comorbidities have a longer LOS, higher medical costs and
more rehospitalizations. No randomized trials were found, however, and only one included
study reached the highest standardized NOS quality score. The pooled-effect measures were
often not appropriate to interpret since the available studies were very heterogeneous [19].
Nevertheless, the (standardized) mean differences of all meta-analyses indicate that medical-
psychiatric comorbidity is indeed related to increased health-economic outcomes. Moreover,
the subgroup of depressed patients shows an increased mean LOS of 4.38 days compared to
patients without depression: this outcome was moderately heterogeneous (I2 = 31%) and was
therefore considered appropriate.
Policy and clinical implications
Our systematic literature review elucidates the importance of medical-psychiatric comorbidi-
ties on health-economic outcomes. It is, consequently, disappointing to find that the quality of
the included studies was mostly limited and that the heterogeneity of study samples was huge.
Future studies on quality improvement strategies should therefore examine the impact of med-
ical-psychiatric comorbidities on health-economic outcomes. This will help care providers and
policy makers to organize care for patients with medical-psychiatric comorbidity in the most
efficient way.
Our literature review suggests that the depressed subgroup of medical-psychiatric comorbid
patients has stronger relationships with health-economics outcomes in comparison to non-
depressed patients. For the first time in literature, we have established that, on average, hospital
inpatients with comorbid depression stay in the hospital 4.38 days longer than non-depressed
patients. In the Netherlands, the costs of a medical inpatient day range from €435 to €575 [66].
Based on the results of our review, the average medical costs in this country for patients with
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comorbid depression are increased to €1905-€2520 compared to patients without comorbid-
ity. Researchers, care providers, policy makers and health insurers might use these outcomes
for future research and healthcare policy making to improve cost-effective care for this sub-
group. Furthermore, future prospective and randomized research should examine the impact
of specific subgroups on health-economic outcomes more thoroughly to help hospitals
improve cost-effective care for different subgroups with medical-psychiatric comorbidity.
Limitations
Although a thorough and extensive electronic search was performed on 6163 titles, this sys-
tematic literature review had several limitations.
First, the included studies were highly heterogenic regarding the patient population, type of
hospital, country and year; thus, the results were difficult to compare, which reduced the possi-
bility of investigating a pooled effect. Therefore, the magnitude of the impact on health-eco-
nomic outcomes remains uncertain.
Ideally, patients with medical-psychiatric comorbidity were compared to studies that exam-
ined the medical and psychiatric illness separately. In this way, it might be possible to examine
whether the effect of different combinations of medical and psychiatric illness was additive or
multiplicative. For reasons of feasibility, our search strategy was narrowed to the impact of
medical-psychiatric comorbidity on inpatients (as opposed to inpatients without psychiatric
comorbidity) on health-economic outcomes. It was anticipated that including all possible
combinations of general medical and psychiatric illnesses in the search would lead to an
unmanageable number of included papers.
Second, in the past decades, the average LOS in hospitals has been largely reduced, which
made it harder to compare studies over time. Publication date was not an exclusion criterion;
hence, some studies were published more than two decades ago. As such, the results in these
studies could reflect hospital-care patterns that have since changed.
Next, the search in the literature list led to the inclusion of eight extra titles. These titles
were not found in the extensive search strategy since they described a specific disorder and the
focus of the search was on medical-psychiatric comorbidity in general. While developing the
electronic search strategy, it was explicitly decided to not include specific disorders since there
was no clear cut-off point to determine when to stop including specific disorders in the search
terms. Furthermore, if all disorders that exist in the literature were included in the search, the
results of the literature search would be too broad.
Subsequently, the studies that examined medical costs had some methodological variation
in terms of sampling and reporting those costs. Some studies examined the impact of total
costs (inpatient, outpatient, pharmacy) and some only the in-hospital costs. Nevertheless, the
evidence of almost all studies concerning the relationship between medical costs and medical-
psychiatric comorbidities pointed in the same direction. Consequently, it was suggested that
comorbidity had an increasing effect on medical costs.
Moreover, the quality of the reviewed studies was variable and only one study received the
full nine stars on the NOS. [17] Thus, the strength of the evidence differed among the three
health-economic outcomes. Most studies examined the impact of medical-psychiatric comor-
bidities on LOS. As 95% of these studies showed an increased LOS, this relationship with med-
ical-psychiatric comorbidities seemed the most reliable.
Another limitation of our study was that only one author rated the included articles. How-
ever, since almost all individual articles found results that pointed in the same direction, the
risk of bias in the studies did not seem to impact the overall findings of this review. Addition-
ally, there is a possible publication bias since only peer-reviewed articles were included. A
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study protocol was not developed in advance of this systematic review; it would therefore be
challenging to note deviations and to assess if the outcomes of the review are reported accord-
ing to the original study plan.
Finally, two subgroups of patients (comorbid depression and delirium) were comprehen-
sively researched and therefore the results of studies that described these subgroups were used
in the meta-analysis. This analysis was not predetermined but carried out post hoc since these
groups appeared to be the most extensively studied in the included papers. Since the search
was not focused on these subgroups, some literature that describes the impact of depression
and a somatic comorbidity on health-economic outcomes may have been overlooked. Never-
theless, future researchers can use the results of this research to examine the impact of sub-
groups with a specific psychiatric disorder and a medical comorbidity.
Despite these limitations, the main conclusions of this review remain valid and clearly indi-
cate, firstly, that general hospital inpatients with medical-psychiatric comorbidities showed
longer LOS, higher medical costs and more rehospitalizations and, secondly, that the subgroup
of depressed patients showed an increased mean LOS of 4.38 days compared to patients with-
out depression.
Conclusion
This systematic literature review found a relationship between medical-psychiatric comorbidi-
ties and health-economic outcomes (LOS, medical costs and rehospitalizations). The meta-
analysis for the subgroup depression showed an increased LOS (on average 4.38 days longer
inpatient stay) compared to patients without depression. These results demonstrate that, on
average, the medical costs for this subgroup are between €1905 and €2550 higher than patients
without a comorbid depression. Policy makers might use these results to improve cost-effec-
tive care for this subgroup. Based on our results, we suggest that future research should exam-
ine the impact of several subgroups with medical-psychiatric comorbidity on health-economic
outcomes more thoroughly.
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